Sanitary pad study sparks concern as experts call for calm

Expert responses to a University of the Free State study on sanitary products have reassured some women, while leaving others uneasy about their menstrual health choices.

The study found that 16 brands of sanitary pads and eight types of pantyliners contained at least two endocrine-disrupting chemicals (EDCs) – substances that some research has linked to hormonal imbalances, infertility, endometriosis and certain cancers.

Health Minister, Aaron Motsoaledi, addressed public concerns during a joint media briefing on Sunday, emphasising that the chemicals detected were present at very low levels.

Motsoaledi urged the public to remain calm, stressing that the study did not establish a direct causal link between the chemicals detected and negative health outcomes in women and girls.

Despite these assurances, some women say the findings have left them uneasy.

One concerned parent, Yvette Mhlauli, says the findings are worrying.

“I’m worried because I’m a mother to a young girl who is growing up and will eventually start needing these products. As much as I trust and respect Dr Aaron’s opinions – because he has shown himself to be reliable in his field – it still scares me that something has been detected.”

Another woman, Anande Khumalo, says the findings have left her feeling conflicted.

“I do worry about my menstrual health and my overall health. But what other option do I have? I feel like I’m backed into a corner.”

Meanwhile, Heather Arends says the findings prompted her to explore alternative menstrual products.

South African Medical Research Council President, Professor Ntobeko Ntusi, has encouraged the public to better understand endocrine-disrupting chemicals and their potential effects.

He also urged researchers to exercise caution when communicating their findings to avoid causing unnecessary public alarm.

“It is important to understand the scientific method and how we link exposures to outcomes through clinical trials or observational studies – something that has not been done in this study,” Ntusi said. “It is critical for scientists in the country to remember the proper avenues for reporting perceived adverse events or concerns through post-marketing surveillance, either through the NDOH or SAHPRA.”

The University of the Free State research team has yet to respond to the expert criticism.

Written by: Realeboga Nke